Implications of mutational spectrum in myelodysplastic syndromes based on targeted next-generation sequencing-Reference-Cited by-同舟云学术

Implications of mutational spectrum in myelodysplastic syndromes based on targeted next-generation sequencing

Published:2017-07-27 Issue:47 Volume:8 Page:82475-82490
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Xu Yuanyuan¹²,Li Yan¹²,Xu Qingyu¹³,Chen Yuelong⁴,Lv Na¹,Jing Yu¹,Dou Liping¹,Bo Jian¹,Hou Guangyuan⁴,Guo Jing⁴,Wang Xiuli⁴,Wang Lili¹,Li Yonghui¹,Chen Chongjian⁴,Yu Li¹⁵

Affiliation:

1. Department of Hematology and BMT center, Chinese PLA General Hospital, Beijing 100853, China

2. Department of Hematology, Hainan Branch of Chinese PLA General Hospital, Sanya 572013, Hainan Province, China

3. Medical school of Nankai University, Tianjin 300071, China

4. Annoroad Gene Technology Co. Ltd, Beijing 100176, China

5. Department of Hematology, General Hospital of Shenzhen University, Shenzhen 518060, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Techniques and Gene Mutations in Myelodysplastic Syndromes;Clinics in Laboratory Medicine;2023-12

2. Some results of a pilot study of mutations in ASXL1 and DNMT3A genes in myelodysplastic syndrome;South Russian Journal of Therapeutic Practice;2023-03-28

3. The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia;International Journal of Molecular Sciences;2023-03-17

4. Comprehensive analysis of genetic factors predicting overall survival in Myelodysplastic syndromes;Scientific Reports;2022-04-08

5. The spectrum of genetic mutations in myelodysplastic syndrome: Should we update prognostication?;eJHaem;2021-11